BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15136777)

  • 1. Avoidance behaviors in patients with implantable cardioverter defibrillators.
    Lemon J; Edelman S; Kirkness A
    Heart Lung; 2004; 33(3):176-82. PubMed ID: 15136777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-assisted computerized education for recipients of implantable cardioverter defibrillators: a randomized controlled trial of the PACER program.
    Kuhl EA; Sears SF; Vazquez LD; Conti JB
    J Cardiovasc Nurs; 2009; 24(3):225-31. PubMed ID: 19390340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and causes of inappropriate detection and therapy by implantable defibrillators of cardioversion in patients with ventricular tachyarrhythmia.
    Chen RH; Chen KP; Wang FZ; Hua W; Chen X; Zhang S
    Chin Med J (Engl); 2006 Apr; 119(7):557-63. PubMed ID: 16620696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource loss predicts depression and anxiety among patients treated with an implantable cardioverter defibrillator.
    Luyster FS; Hughes JW; Waechter D; Josephson R
    Psychosom Med; 2006; 68(5):794-800. PubMed ID: 17012535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological and clinical problems in young adults with implantable cardioverter-defibrillators.
    Wójcicka M; Lewandowski M; Smolis-Bak E; Szwed H
    Kardiol Pol; 2008 Oct; 66(10):1050-8; discussion 1059-60. PubMed ID: 19006026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life in pediatric patients with implantable cardioverter defibrillators.
    Sears SF; Hazelton AG; St Amant J; Matchett M; Kovacs A; Vazquez LD; Fairbrother D; Redfearn S; Hanisch D; Dubin A; Cannon BC; Fishbach P; Kanter R; Bryant RM
    Am J Cardiol; 2011 Apr; 107(7):1023-7. PubMed ID: 21256464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and cause of anxiety in patients with an implantable cardioverter-defibrillator: a longitudinal two-year follow-up.
    Crössmann A; Pauli P; Dengler W; Kühlkamp V; Wiedemann G
    Heart Lung; 2007; 36(2):87-95. PubMed ID: 17362789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concerns about the implantable cardioverter defibrillator: a determinant of anxiety and depressive symptoms independent of experienced shocks.
    Pedersen SS; van Domburg RT; Theuns DA; Jordaens L; Erdman RA
    Am Heart J; 2005 Apr; 149(4):664-9. PubMed ID: 15990750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure.
    Spencker S; Coban N; Koch L; Schirdewan A; Müller D
    Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in anxiety and concerns about the cardioverter defibrillator.
    Spindler H; Johansen JB; Andersen K; Mortensen P; Pedersen SS
    Pacing Clin Electrophysiol; 2009 May; 32(5):614-21. PubMed ID: 19422582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy.
    Lin G; Nishimura RA; Gersh BJ; Phil D; Ommen SR; Ackerman MJ; Brady PA
    Heart; 2009 May; 95(9):709-14. PubMed ID: 19282314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life.
    Bostwick JM; Sola CL
    Psychiatr Clin North Am; 2007 Dec; 30(4):677-88. PubMed ID: 17938040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inappropriate implantable cardioverter-defibrillator discharges unrelated to supraventricular tachyarrhythmias.
    Occhetta E; Bortnik M; Magnani A; Francalacci G; Marino P
    Europace; 2006 Oct; 8(10):863-9. PubMed ID: 16916859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled trial of secondary prevention of anxiety and distress in a German sample of patients with an implantable cardioverter defibrillator.
    Crössmann A; Schulz SM; Kühlkamp V; Ritter O; Neuser H; Schumacher B; Bauer W; Pauli P
    Psychosom Med; 2010 Jun; 72(5):434-41. PubMed ID: 20410252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychological aspects of cardiac devices and recalls in patients with implantable cardioverter defibrillators.
    Sears SF; Conti JB
    Am J Cardiol; 2006 Aug; 98(4):565-7. PubMed ID: 16893718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICD: a qualitative study of patient experience the first year after implantation.
    Kamphuis HC; Verhoeven NW; Leeuw R; Derksen R; Hauer RN; Winnubst JA
    J Clin Nurs; 2004 Nov; 13(8):1008-16. PubMed ID: 15533107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leisure-time activities of patients with ICDs: findings of a survey with respect to sports activity, high altitude stays, and driving patterns.
    Kobza R; Duru F; Erne P
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):845-9. PubMed ID: 18684281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shocks, personality, and anxiety in patients with an implantable defibrillator.
    Van den Broek KC; Nyklícek I; Van der Voort PH; Alings M; Denollet J
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):850-7. PubMed ID: 18684282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychopathology in patients with ICDs over time: results of a prospective study.
    Kapa S; Rotondi-Trevisan D; Mariano Z; Aves T; Irvine J; Dorian P; Hayes DL
    Pacing Clin Electrophysiol; 2010 Feb; 33(2):198-208. PubMed ID: 19930108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks.
    Tzeis S; Andrikopoulos G; Kolb C; Vardas PE
    Europace; 2008 Nov; 10(11):1256-65. PubMed ID: 18708639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.